抗心律失常药物的新靶点及新药研发  

Innovative approaches to anti-arrhythmic drug therapy

作　　者：冒玉娟 陈鑫[2] 

机构地区：[1]江苏牧畜兽医职业技术学院,泰州225300 [2]中国药科大学,南京210000

出　　处：《海峡药学》2009年第9期76-79,共4页Strait Pharmaceutical Journal

摘　　要：正常心脏功能依赖于适当而规律的心跳速率(心率)。当心率太快或太慢时,心脏功能可能发生障碍,伴随着从轻度乃至危及生命并发症的可能。过去,依靠药物治疗心律失常很困难因为缺乏有效性同时又伴有高风险的并发症。一些最新进展为开发新型的、优越的心律失常治疗方法开辟了令人振奋的可能性。文章就药物治疗心房颤动及心室颤动两种常见心律失常的最新进展和前景进行综述。Normal cardiac function requires an appropriate and regular beating rate （cardiac rhythm）. When the heart rhythm is too fast or too slow, cardiac function can be impaired, with derangements that vary from mild symptoms to life-threatening complications. In the past, drug treatment of cardiac arrhythmias has proven difficult, both because of inadequate effectiveness and a risk of serious complications. However, a variety of recent advances have opened up exciting possibilities for the development of novel and superior approaches to arrhythmia therapy. This article will review recent progress and future prospects for treating two particularly important cardiac arrhythmias：atrial fibrillation and ventricular fibrillation.

关 键 词：靶点 心律失常 药物治疗 

分 类 号：R972.2[医药卫生—药品]